Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Cross-reactivity00:42

Cross-reactivity

Overview
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Vaccine-Associated Maintenance of Epithelial Integrity Correlated With Protection Against Virus Entry.

The Journal of infectious diseases·2018
Same author

Vaccine-modified NF-kB and GR signaling in cervicovaginal epithelium correlates with protection.

Mucosal immunology·2017
Same author

Probing lepton flavour violation via neutrinoless [Formula: see text] decays with the ATLAS detector.

The European physical journal. C, Particles and fields·2017
Same author

A new method to distinguish hadronically decaying boosted <i>Z</i> bosons from <i>W</i> bosons using the ATLAS detector.

The European physical journal. C, Particles and fields·2017
Same author

Measurement of the centrality dependence of the charged-particle pseudorapidity distribution in proton-lead collisions at [Formula: see text] TeV with the ATLAS detector.

The European physical journal. C, Particles and fields·2017
Same author

Search for new phenomena in events with at least three photons collected in <i>pp</i> collisions at [Formula: see text] = 8 TeV with the ATLAS detector.

The European physical journal. C, Particles and fields·2017
Same journal

A viral ORFeome library for systems-level genetic dissection of host-pathogen interactions.

Cell·2026
Same journal

Co-option of lysosomal machinery shapes the evolution of the intracellular photosymbiosis supporting coral reefs.

Cell·2026
Same journal

LEF1 and niche factors determine T cell stemness across chronic diseases.

Cell·2026
Same journal

Recurrent patterns of TOP1-mediated neuronal genomic damage shared by major neurodegenerative disorders.

Cell·2026
Same journal

Four-dimensional molecular mapping from a spatial snapshot reveals the dynamics of hair follicle organogenesis.

Cell·2026
Same journal

Whole-cell particle-based digital twin simulations from 4D lattice light-sheet microscopy data.

Cell·2026
Ver todos los artículos relacionados

Video Experimental Relacionado

Updated: Jun 25, 2026

Isolation of Fidelity Variants of RNA Viruses and Characterization of Virus Mutation Frequency
18:10

Isolation of Fidelity Variants of RNA Viruses and Characterization of Virus Mutation Frequency

Published on: June 16, 2011

Variación antigénica en el virus visna.

J V Scott, L Stowring, A T Haase

    Cell
    |October 1, 1979
    PubMed
    Resumen
    Este resumen es generado por máquina.

    El virus de Visna sufre variación antigénica a través de mutaciones en su gen de glicoproteína, no recombinación. Esto conduce a distintas variantes virales que evaden las respuestas inmunes del huésped.

    Más Videos Relacionados

    Propagating and Detecting an Infectious Molecular Clone of Maedi-visna Virus that Expresses Green Fluorescent Protein
    08:49

    Propagating and Detecting an Infectious Molecular Clone of Maedi-visna Virus that Expresses Green Fluorescent Protein

    Published on: October 9, 2011

    Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
    08:09

    Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

    Published on: March 24, 2017

    Videos de Experimentos Relacionados

    Last Updated: Jun 25, 2026

    Isolation of Fidelity Variants of RNA Viruses and Characterization of Virus Mutation Frequency
    18:10

    Isolation of Fidelity Variants of RNA Viruses and Characterization of Virus Mutation Frequency

    Published on: June 16, 2011

    Propagating and Detecting an Infectious Molecular Clone of Maedi-visna Virus that Expresses Green Fluorescent Protein
    08:49

    Propagating and Detecting an Infectious Molecular Clone of Maedi-visna Virus that Expresses Green Fluorescent Protein

    Published on: October 9, 2011

    Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
    08:09

    Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

    Published on: March 24, 2017

    Área de la Ciencia:

    • Virología Virología.
    • Inmunología Inmunología.
    • Biología Molecular Biología Molecular

    Sus antecedentes:

    • El virus Visna causa una infección lenta y persistente en las ovejas.
    • La variación antigénica es un mecanismo clave para la evasión inmune en los lentivirus.

    Objetivo del estudio:

    • Para investigar la base genética de la variación antigénica en el virus visna.
    • Para diferenciar entre la mutación y la recombinación como la causa de la generación de variantes.

    Principales métodos:

    • Aislamiento y caracterización de las variantes antigénicas secuenciales (LV1-1, LV1-4) de ovejas infectadas.
    • Análisis comparativo de mapas péptidos para la glicoproteína de envoltura (gp135) y las proteínas centrales (p30, p16, p14).
    • Digestión de la ribonucleasa T1 para comparar los patrones de oligonucleótidos de ARN.

    Principales resultados:

    • Se identificaron dos variantes antigénicas distintas, LV1-1 y LV1-4.
    • Solo la glicoproteína gp135 del sobre mostró diferencias en los mapas péptidos entre las variantes.
    • Los mapas de ARN eran idénticos, y sólo unos pocos fragmentos de péptidos en gp135 fueron alterados.
    • gp135 fue identificado como el polipéptido inmunodominante que provoca anticuerpos neutralizantes.

    Conclusiones:

    • La mutación dentro del gen de la glicoproteína del virus visna es el probable impulsor de la variación antigénica.
    • La recombinación es menos probable dada la estabilidad genética observada de otros componentes virales.
    • Comprender este mecanismo es crucial para desarrollar estrategias efectivas de control del virus visna.